title: Diabetes Device Interoperability for Improved Diabetes Management.
abstract: Scientific and technological advancements have led to the increasing availability and use of sophisticated devices for diabetes management, with corresponding improvements in public health. These devices are often capable of sharing data with a few other specific devices but are generally not broadly interoperable; they cannot work together with a wide variety of other devices. As a result of limited interoperability, benefits of modern diabetes devices and potential for development of innovative new diabetes technologies are not being fully realized. Here we discuss diabetes device interoperability in general, then focus on 4 examples that show how diabetes management could benefit from enhanced interoperability: remote monitoring and data sharing, integrating data from multiple devices to better inform diabetes management strategies, device consolidation, and artificial pancreas development.
authors.affiliation: US Food and Drug Administration, Silver Spring, MD, USA alain.silk@fda.hhs.gov.
authors.forename: Alain D
authors.initials: AD
authors.lastname: Silk
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D015190:Blood Glucose Self-Monitoring; D003920:Diabetes Mellitus / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D015918:Infusion Pumps, Implantable / Q000592:standards / Q000639:trends; D007328:Insulin / Q000008:administration & dosage*; D007332:Insulin Infusion Systems / Q000592:standards / Q000639:trends; D019397:Pancreas, Artificial / Q000592:standards / Q000639:trends; D017216:Telemedicine / Q000379:methods / Q000592:standards / Q000639:trends*
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin
keywords: artificial pancreas; continuous glucose monitor; diabetes; insulin pump; interoperability